Expression of the intercellular adhesion molecule ICAM-1 on alveolar macrophages in healthy subjects and non-small cell lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 276s Year: 2002
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013
Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013
Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013
Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017
Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Expression of LFA-1 and L-selectin on PMN and level of soluble sE-selectin and sL-selectin in patients with small cell lung cancer (SCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002
Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014
Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients Source: Eur Respir J 2002; 19: 472-478 Year: 2002
Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014
Measurement of trefoil factor peptides in bronchioalveolar lavage (BAL) fluids from patients with COPD or pulmonary cancer Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005
Surface activation molecules and intracellular cytokines in bronchoalveolar lavage (BAL) and blood CD3+ cells in advanced sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 350s Year: 2002
Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013
Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 201s Year: 2003